Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand

Key Takeaways Globus Medical's Q2 adjusted EPS rose 14.1% to $0.86, topping estimates by 13.16%.GMED's revenues grew 18.4% to $745.3M, with Nevro adding $95M in the quarter.Globus Medical's gross margin expanded 792 bps to 66.6% as the cost of sales fell 4.3%.Globus Medical, Inc. (GMED) reported second-quarter 2025 adjusted earnings per share (EPS) of 86 cents, which surpassed the Zacks Consensus Estimate by 13.16%. The figure increased 14.1% year over year.Adjusted EPS excludes certain non-recurring expens ...